SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
161 Rick, there are still some of us out here who have not sold our stock. We haveFred McCutcheon-2/4/1997
160 Harold, I wish I had waited also.MikeMichael H. Dragon-1/22/1997
159 You know, I've bought and held Biogen for 3 years...you'd think I couldHarold Engstrom-1/22/1997
158 Harold, a couple of thoughts. Lets discuss the importance of book value in a biVector1-1/22/1997
157 Vector, thanks for your complement. I don't know much about genomics comHarold Engstrom-1/20/1997
156 Re: Raymond James... These guys had no biotech analyst after Tony Bulter left Rick Lundberg-1/20/1997
155 Harold, I think Reijer Lenstra (Smith Barney's biotec analyst) has been reaVector1-1/20/1997
154 Harold, Smith Barney just downgraded Biogen based on price. Michael H. Dragon-1/20/1997
153 Mike, good point: it is strange that analysts seem to jump on so late in the gaHarold Engstrom-1/20/1997
152 Mike, I also sold my Biogen position on Friday. Biogen appears to breakout for Cynic 2005-1/19/1997
151 Harold, absent a market or sector correction I dont think BGEN will be much cheVector1-1/19/1997
150 Harold,I find it interesting that Raymond James initiated coverage of Biogen FrMichael H. Dragon-1/18/1997
149 Michael, I agree with your analysis. Biogen is a very attractive company, butHarold Engstrom-1/17/1997
148 Mohan, while the outcome of aimm's phase 3 trials are due out in the next cMichael H. Dragon-1/17/1997
147 BIOGEN REPORTS FOURTH QUARTER AND 1996 RESULTS (If you have trouble reading thRick Lundberg-1/14/1997
146 Welcome back, I hope you had an enjoyable vacation. Its good to have you back oVector1-1/14/1997
145 ========================================================================== RickRick Lundberg-1/14/1997
144 Charts for previous post: -------------------------------------------Rick Lundberg-1/14/1997
143 Back from vacation and H&Q... Let us all bow our heads for the reading of Rick Lundberg-1/14/1997
142 Harold, I agree with your analysis of the market acceptance of Avonex. I have aVector1-1/10/1997
141 You could be right, Mohan. Maybe Rick has an answer for us. HaroldHarold Engstrom-1/10/1997
140 Harold, do you know any thing about the Auto Immune's oral MS drug which isCynic 2005-1/10/1997
139 I do think $2 is reasonable. I own the stock, and so could be accused of bias,Harold Engstrom-1/10/1997
138 Harold, do you really believe that $2 per share is reasonable. THe mean from thVector1-1/9/1997
137 Dirk, OK you asked for it. You are right! You are right! You are right! You areCynic 2005-1/9/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News